Transient tachypnoea of the neonate (TTN) · women undergoing planned elective caesarean section at 37 weeks' gestation and beyond for singleton pregnancy
Effect of antenatal corticosteroids (betamethasone) showed no clear difference in transient tachypnoea of the neonate (TTN) compared with usual care prior to planned caesarean at term on maternal and… (low certainty).
1 finding from 1 review
Admission to neonatal special care (all levels) for respiratory morbidity · women undergoing planned elective caesarean section at 37 weeks' gestation and beyond for singleton pregnancy
Effect of antenatal corticosteroids (betamethasone) probably leads to lower admission to neonatal special care (all levels) for respiratory… compared with usual care prior to planned caesarean at term on maternal and… (moderate certainty).
1 finding from 1 review
Need for mechanical ventilation · women undergoing planned elective caesarean section at 37 weeks' gestation and beyond for singleton pregnancy
It is very uncertain whether effect of antenatal corticosteroids (betamethasone) changes need for mechanical ventilation compared with usual care prior to planned caesarean at term on maternal and… (very low certainty).
1 finding from 1 review
Neonatal hypoglycaemia · women undergoing planned elective caesarean section at 37 weeks' gestation and beyond for singleton pregnancy
1 finding from 1 review
Severe maternal morbidity and mortality index · women undergoing planned elective caesarean section at 37 weeks' gestation and beyond for singleton pregnancy
1 finding from 1 review
Maternal development of postpartum infection/pyrexia in the first 72 hours · women undergoing planned elective caesarean section at 37 weeks' gestation and beyond for singleton pregnancy
1 finding from 1 review
Hypoglycaemia · women with type 2 diabetes
It is very uncertain whether infant outcomes: oral anti‐diabetic agent (metformin) changes hypoglycaemia compared with insulin (very low certainty).
1 finding from 1 review
Health status and well‐being – neonatal morbidity and mortality combined · women with type 2 diabetes
1 finding from 1 review
Neurosensory disability · women with type 2 diabetes
1 finding from 1 review
Childhood/adulthood adiposity · women with type 2 diabetes
1 finding from 1 review
Childhood/adulthood diabetes · women with type 2 diabetes
1 finding from 1 review
Large‐for‐gestational age · women with type 2 diabetes
It is very uncertain whether infant outcomes: oral anti‐diabetic agent (metformin) changes large‐for‐gestational age compared with insulin (very low certainty).
1 finding from 1 review
Perinatal mortality · women with type 2 diabetes
1 finding from 1 review
Hypertensive disorders of pregnancy: pre‐eclampsia · women with type 2 diabetes
It is very uncertain whether maternal outcomes: oral anti‐diabetic agent (metformin) changes hypertensive disorders of pregnancy: pre‐eclampsia compared with insulin (very low certainty).
1 finding from 1 review
Hypertensive disorders of pregnancy (pregnancy‐induced hypertension) · women with type 2 diabetes
Maternal outcomes: oral anti‐diabetic agent (metformin) may leads to lower hypertensive disorders of pregnancy: pregnancy‐induced hypertension compared with insulin (low certainty).
1 finding from 1 review
Caesarean section · women with type 2 diabetes
Maternal outcomes: oral anti‐diabetic agent (metformin) may leads to lower caesarean section compared with insulin (low certainty).
1 finding from 1 review
Induction of labour · women with type 2 diabetes
It is very uncertain whether maternal outcomes: oral anti‐diabetic agent (metformin) changes induction of labour compared with insulin (very low certainty).
1 finding from 1 review
Perineal trauma · women with type 2 diabetes
1 finding from 1 review
Postnatal depression · women with type 2 diabetes
1 finding from 1 review
Postnatal weight retention · women with type 2 diabetes
1 finding from 1 review